Companies: 10,795·Total market cap: $144.5T
Nova Eye Medical Limited

Nova Eye Medical Limited

ELXMFOTCHealthcare● Active
$0.00
$-0.01(-86.72%)
Market Cap$541249
P/E Ratio—
52W High$0.1
52W Low$0.0019
Cash on HandFinancialsRevenue

Nova Eye Medical Limited (ELXMF) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

ELXMF · cash on hand · updated Jun 30, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$5.1M▼ -17.8% vs prior year
FY · as of Jun 30, 2025 · Reported in AUD
Cash & Cash Equiv. (CCE)
$5.1M
cashAndCashEquivalents
Short-Term Investments
$0
shortTermInvestments
YoY Change vs Prior Year
-17.8%
vs prior fiscal year
Latest Quarter
$2.6M
Q4 2025
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in AUD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: June 30, 2025

Net cash vs debt

Cash & ST Investments$5.1MCash on Hand
Total Debt$3.0MTotal Debt
Net Cash / Net Debt+$2.0MNet Cash Position
Cash vs Debt Ratio
Cash 63%Debt 37%

Nova Eye Medical Limited has a net cash position of $2.0M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$5.1M − $3.0M = +$2.0M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
ELXMF annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Jun 30, 2025Latest$5.1M-17.8%
Jun 30, 2024$6.2M-17.1%
Jun 30, 2023$7.4M-7.3%
Jun 30, 2022$8.0M-55.1%
Jun 30, 2021$17.8M-81.4%
ELXMF cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.6%#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.5%#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Nova Eye Medical Limited
Nova Eye Medical LimitedYOU
ELXMF
$5.1M124.0%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Nova Eye Medical Limited (ELXMF) cash on hand as of June 30, 2025 is $5.1M, comprising $5.1M in cash and cash equivalents (CCE) plus $0 in short-term investments — reported as Nova Eye Medical Limited cash and short-term investments on the balance sheet (10-K filing). Also referred to as Nova Eye Medical Limited cash reserves or cash position.

Nova Eye Medical Limited annual cash on hand history shows decreased -17.8% in 2025: decreased -17.8% in 2025. Nova Eye Medical Limited cash reserves in 2025 reflect the company's capital allocation strategy.

Nova Eye Medical Limited carries total debt of $3.0M against cash of $5.1M, resulting in a net cash position of +$2.0M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.
Financial statementsFree cash flowNet incomeRevenueMarket capP/E ratioEarningsPrice history

Frequently asked questions

ELXMF cash on hand · 5 questions

As of June 30, 2025, Nova Eye Medical Limited (ELXMF) has $5,055,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $5,055,000 in cash and cash equivalents (CCE) plus $0 in short-term investments. Latest quarter (December 31, 2025): $2,621,968. Data sourced from the annual 10-K filing via FMP.

ELXMF cash on handELXMF cash reservesELXMF cash 2025how much cash does ELXMF have

▸ Source: FMP /balance-sheet-statement · US GAAP · Nova Eye Medical Limited · Nova Eye Medical Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: June 30, 2025